Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2017-10-18

Clinical Trial Update: Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection

View source ↗

Summary

This clinical trial update discusses adverse drug reactions observed with anti-tuberculosis drugs used to treat latent tuberculosis infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hanyang University | Conditions: Latent Tuberculosis Infection | Status: UNKNOWN